3103 studies found for:    Open Studies | "Metabolic Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Metabolic Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Chung-ju Metabolic Disease Cohort (CMC) Study
Condition: Metabolic Diseases
2 Recruiting Quality of Life of Patients and Theirs Parents With Inherited Metabolic Diseases With Restricted Diet
Condition: Inherited Metabolic Diseases Requiring Restrictive and Specific Diet
Intervention: Behavioral: data assessment of the state of health and quality of life of patients and their families
3 Recruiting Hepatocyte Transplantation for Liver Based Metabolic Disorders
Condition: Metabolic Diseases
Interventions: Drug: human hepatocyte transplantation;   Radiation: Preparative Radiation Therapy
4 Recruiting Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
Condition: Metabolic Disorders
5 Recruiting MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
6 Recruiting Natural History Study of Children With Metachromatic Leukodystrophy
Conditions: Leukodystrophy, Metachromatic;   Hereditary Central Nervous System Demyelinating Diseases;   Brain Diseases, Metabolic, Inborn;   Brain Diseases, Metabolic;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Sulfatidosis;   Sphingolipidoses;   Lysosomal Storage Diseases, Nervous System;   Leukoencephalopathies;   Demyelinating Diseases;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Lipidoses;   Lipid Metabolism, Inborn Errors;   Lysosomal Storage Diseases;   Metabolic Diseases;   Lipid Metabolism Disorders
Intervention: Other: Natural History Study of Children With Metachromatic Leukodystrophy
7 Recruiting Impact of Peer Support on Diabetes in China
Conditions: Glucose Metabolism Disorders;   Metabolic Diseases;   Endocrine System Diseases;   Diabetes
Interventions: Behavioral: peer support;   Other: usual education lectures
8 Recruiting Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique
Conditions: Diabetes Mellitus;   Insulin Resistance;   Glucose Metabolism Disorders;   Metabolic Diseases;   Endocrine System Diseases
Interventions: Drug: 6-DIG;   Procedure: clamp
9 Unknown  Pharmacokinetics Study of Gamma-aminobutyric Acid
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Metabolic Diseases;   Endocrine System Diseases;   Autoimmune Diseases;   Immune System Diseases
10 Unknown  Aldosterone and the Metabolic Syndrome
Conditions: Metabolic Diseases;   Diabetes Mellitus;   Endocrine System Diseases;   Glucose Metabolism Disorders
Interventions: Drug: Renin-Angiotensin-Aldosterone System (RAAS) Activation;   Drug: Administration of Aliskiren, Spironolactone, or Placebo;   Drug: Increased Dose, Combination, or Placebo
11 Recruiting A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders
Condition: Metabolic Disorders
Intervention: Biological: ProHema-CB Transplant
12 Recruiting EPI-743 for Metabolism or Mitochondrial Disorders
Conditions: Undiagnosed Diseases;   Metabolic Disease;   Neurology;   Myoptahy;   Oxidation/Reduction;   Mitochondrial Disorders
Intervention: Drug: EPI-743
13 Recruiting Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
Conditions: Liver Diseases, Alcoholic;   Metabolic Diseases
Intervention: Other: Intervention according to the standard of care.
14 Unknown  The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney Disease
Conditions: Metabolic Diseases;   Chronic Kidney Disease
15 Recruiting Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome
Conditions: Obesity;   Metabolic Disease
Interventions: Drug: Colchicine 0.6 mg given;   Drug: Placebo capsules given
16 Unknown  Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic Patients
Condition: Nutritional and Metabolic Disease
Interventions: Dietary Supplement: vitamin D3 supplement;   Dietary Supplement: calcium supplement;   Dietary Supplement: vitamin D3 and calcium supplement;   Dietary Supplement: placebo
17 Recruiting Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
Conditions: HIV;   Lipodystrophy
18 Recruiting UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Conditions: Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn
Intervention: Biological: DUOC-01
19 Unknown  Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients
Conditions: it is a Group of Metabolic Diseases in;   Which a Person Has High Blood Sugar, Either;   Because the Body Does Not Produce Enough Insulin,;   or Because Cells do Not Respond to the Insulin That;   is Produced.
Intervention: Drug: Taurine
20 Recruiting Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance
Condition: Gastric Cancer With Metabolic Syndrome or Metabolic Disease
Interventions: Procedure: subtotal gastrectomy with gastroduodenostomy;   Procedure: subtotal gastrectomy with Roux-en-Y gastrojejunostomy,;   Procedure: total gastrectomy with Rou-en-Y esophagojejunostomy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years